HRS-5965 not checked

Hengrui

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
14 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Primary IgA Nephropathy (2 trials), Paroxysmal Nocturnal Hemoglobinuria
Main trialPhase 3
“This multicenter, randomized, double-blind, parallel, placebo-controlled study is being conducted to evaluate the efficacy, and safety of HRS-5965 capsule for primary IgA nephropathy.”In the company’s words, NCT07014826 on ClinicalTrials.gov

Other drugs for Primary IgA Nephropathy

All 39 drugs for Primary IgA Nephropathy

Coming up3

Changes1

Last 90 days

Trials14

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Oct 2027 A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
Phase 2Active, not recruiting Dec 2027 Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Phase 2Recruiting Jul 2029 A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy
Phase 3Completed 31 Jul 2025 A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy
Phase 3Completed 6 Jan 2026 Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment
Phase 2Completed 25 Mar 2024 Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Phase 2Completed 17 Oct 2025 A Trial of HRS-5965 Tablets in Primary IgA Nephropathy
Phase 1Completed 3 Nov 2023 Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency
Phase 1Completed 6 Aug 2024 Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects
Phase 1Completed 8 Oct 2024 A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers
Phase 1Completed 7 Apr 2025 A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects
Phase 1Completed 22 Jul 2025 A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects
Phase 1Completed 17 Aug 2025 Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects
Phase 1Completed 16 Jan 2026 Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow HRS-5965

Following is part of Solo: you see every change to HRS-5965 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in